- Home
- YIBO vs CNTX Comparison
YIBO vs CNTX Comparison
Compare YIBO & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YIBO
- CNTX
- Stock Information
- Founded
- YIBO 2011
- CNTX 2015
- Country
- YIBO China
- CNTX United States
- Employees
- YIBO N/A
- CNTX N/A
- Industry
- YIBO
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- YIBO
- CNTX Health Care
- Exchange
- YIBO NYSE
- CNTX Nasdaq
- Market Cap
- YIBO 71.7M
- CNTX 60.7M
- IPO Year
- YIBO 2024
- CNTX 2021
- Fundamental
- Price
- YIBO $1.22
- CNTX $0.80
- Analyst Decision
- YIBO
- CNTX Strong Buy
- Analyst Count
- YIBO 0
- CNTX 6
- Target Price
- YIBO N/A
- CNTX $6.50
- AVG Volume (30 Days)
- YIBO 18.6K
- CNTX 96.5K
- Earning Date
- YIBO 05-16-2025
- CNTX 05-07-2025
- Dividend Yield
- YIBO N/A
- CNTX N/A
- EPS Growth
- YIBO N/A
- CNTX N/A
- EPS
- YIBO 0.13
- CNTX N/A
- Revenue
- YIBO $149,828,000.00
- CNTX N/A
- Revenue This Year
- YIBO N/A
- CNTX N/A
- Revenue Next Year
- YIBO N/A
- CNTX N/A
- P/E Ratio
- YIBO $9.30
- CNTX N/A
- Revenue Growth
- YIBO N/A
- CNTX N/A
- 52 Week Low
- YIBO $0.95
- CNTX $0.55
- 52 Week High
- YIBO $17.47
- CNTX $2.75
- Technical
- Relative Strength Index (RSI)
- YIBO 49.09
- CNTX 44.94
- Support Level
- YIBO $1.18
- CNTX $0.74
- Resistance Level
- YIBO $1.28
- CNTX $0.85
- Average True Range (ATR)
- YIBO 0.09
- CNTX 0.09
- MACD
- YIBO 0.03
- CNTX -0.02
- Stochastic Oscillator
- YIBO 46.84
- CNTX 13.30
About YIBO PLANET IMAGE INTERNATIONAL LIMITED
Planet Image International Ltd is engaged in manufacturing and selling compatible toner cartridges. It develops and manufactures toner cartridges that are compatible with, and can be used in, a wide range of commonly available models of laser printers from different manufacturers, or compatible toner cartridges, on a white-label or third-party brand basis or under its self-owned brands. The company also sells its branded products through online sales channels under four brands, TrueImage, CoolToner, AZtech, and Toner Bank. The company operates in North America, Europe, and Other countries.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.